Trial Profile
Acute recoil associated with ABSORB bioresorbable vascular scaffold (BVS) versus everolimus-eluting metallic stent (EES) in real world population
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Oct 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 21 Oct 2016 New trial record